Topical Advisory Panel Members' Collection Series: Nanocarriers for Alternative Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 242
Special Issue Editors
Interests: quality by design-based formulation strategies; regulatory science; patient centeredness in dosage form design; alternative administration routes; nose-to-brain delivery
Special Issues, Collections and Topics in MDPI journals
Interests: nose-to-brain delivery; nanomedicine; albumin nanoparticles; polymeric micelles; freeze-drying
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, alternative drug delivery routes have become the focus of research and development with the aim of satisfying patient expectations by applying simple and effective drug therapy avoiding invasive medication. Utilization of alternative drug delivery routes, such as nasal, pulmonary, ocular. or dermal routes, indicates several advantages (e.g., targeted therapy, bypassing biological barriers, a chance to minimize therapeutic dose, or minimization of side effects); however, from a technological point of view, it might be challenging to transport the drug to the target site. To overcome these hurdles, the variety of smart nanocarriers (e.g., lipid-, polymeric-, or protein-based systems) means an innovative approach.
The aim of this Special Issue is to describe the latest findings related to i) the development, optimization, and characterization of novel nanocarrier systems intended for alternative drug delivery, ii) the improvement of physicochemical and pharmacokinetic properties of drugs with the application of nanocarrier systems, and iii) the utilization of alternative drug delivery routes for advanced therapy.
In this Special Issue, original research articles, communication papers, and reviews are welcome.
We look forward to receiving your contributions.
Prof. Dr. Ildikó Csóka
Dr. Katona Gábor
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicine
- biomaterials
- functional nanomaterials
- alternative administration route
- targeted delivery
- improved bioavailability
